Clinical trials
Phase 3 Lung Diseases, Obstructive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 15 |
| Novartis Pharmaceuticals | 3 |
| Grifols Therapeutics LLC | 1 |
| Johns Hopkins Bloomberg School of Public Health | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Obstructive | 21 |
| Lung Diseases | 20 |
| Respiratory Tract Diseases | 18 |
| Asthma | 15 |
| Bronchial Diseases | 14 |
| Pulmonary Disease, Chronic Obstructive | 6 |
| Emphysema | 2 |
| Hypersensitivity | 2 |
| Immune System Diseases | 2 |
| Pathologic Processes | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.